PINS-N 3.62 OWL-N 1.16 AC-T 0.83 LVMUY-OTC 0 ACN-N 14.19 UNH-N -1.89 VALT-T -1.12
Akumin Inc. (AKU-T)

Akumin Inc. (AKU-T)

73 watching

TSE:AKU

0.53
0.02 (3.92%) 1d
Feb 1, 2024, 8:19 pm
0

Related posts

Nervous markets await Nvidia
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Akumin Inc. (AKU-T) was once a popular entity during the dot-com era, leveraging a niche that thrived in a time when internet speeds were notably slower. However, experts suggest that the company’s services may not hold the same relevance given the advancements in internet technology, which have drastically improved connectivity and reduced the need for such services. As a result, the once high demand for Akumin's offerings appears diminished, raising questions about its long-term viability in a rapidly evolving tech landscape. Reviewers express concerns about whether the business can adapt to the current market demands or if it risks becoming obsolete. Without a significant shift in business strategy or service enhancement, the future outlook for Akumin may be challenging.

Consensus
Negative
Valuation
Overvalued
Similar
CTSH, CTSH
COMMENT

Akumin Inc.(AKU-T)

Sep 09, 2024

It was popular in the dot com years. Its service isn't as needed now since Internet speed is way better.

Teal LindeTeal Linde
Unknown
Unlock Rating
$0.530

Stock price when the opinion was issued

medical services
DON'T BUY

Akumin Inc.(AKU-T)

Apr 13, 2023

Challenge was that to get this business where it is, they had to do a lot of acquisitions and take on a lot of debt. Tough environment for companies with debt, stock's under pressure. Follows it. Great business, good growth. Don't buy here.

James TelfserJames Telfser
No
Unlock Rating
$0.780

Stock price when the opinion was issued

medical services
HOLD

Akumin Inc.(AKU-T)

Jun 09, 2021
A frustrating position. Imaging clinics in the US. Performing well and acquiring clinics. Higher margins than peers. Positive news has come out, so the rest of the year should be better, closing the gap in the valuation. Generating free cashflow and paying down debt. Alzheimer's drug will push organic demand for scans.
James TelfserJames Telfser
Owned
Unlock Rating
$3.520

Stock price when the opinion was issued

medical services
BUY

Akumin Inc.(AKU-T)

Apr 20, 2021
A past top pick. It's the second-largest US imaging diagnostics clinic operator. They have a large presence in Texas and Florida which are reopening. AKU is rebounding from last year, when they kept margins strong. Revenue growth has rebounded well as well as volume growth. They weathered 2020 lockdowns well. Their last quarter changed accounting practices, which confused the street, but that's straightened out now. A positive outlook.
James TelfserJames Telfser
Owned
Unlock Rating
$3.920

Stock price when the opinion was issued

medical services
PAST TOP PICK

Akumin Inc.(AKU-T)

Feb 17, 2021
(A Top Pick Jan 22/20, Up 3%) Operates MRI clinics in the US. Hurt by pandemic in organic revenue growth, but managed well through it. Still a great story.
James TelfserJames Telfser
Owned
Unlock Rating
$4.890

Stock price when the opinion was issued

medical services
TOP PICK

Akumin Inc.(AKU-T)

Feb 17, 2021
At an inflection point. Technology, right clinics, and right billing cycle to drive free cashflow, which is the lifeblood to being a consolidation play. US institutions are interested in it. Demographics are in their favour, a massive tailwind. No dividend. (Analysts’ price target is $5.24)
James TelfserJames Telfser
Owned
Unlock Rating
$4.890

Stock price when the opinion was issued

medical services
PAST TOP PICK

Akumin Inc.(AKU-T)

Oct 15, 2020
(A Top Pick Oct 15/19, Up 20%) Operates MRI clinics in the US. Now second largest in the US. Can consolidate and grow. Substantial margins in the mid-20s. Impressive management team. Still likes it at these levels.
James TelfserJames Telfser
Owned
Unlock Rating
$4.450

Stock price when the opinion was issued

medical services
BUY

Akumin Inc.(AKU-T)

Jun 03, 2020
The company has MRI clinics in the US. It has over 100 clinics now. He thinks it is a fantastic buy at this level. The challenge is their balance sheet, because of their unfortunate timing of an acquisition just as the pandemic hit. He thinks they will manage it just fine. Margins will be strong when things return to normal for this small cap.
James TelfserJames Telfser
Unknown
Unlock Rating
$2.950

Stock price when the opinion was issued

medical services
HOLD

Akumin Inc.(AKU-T)

Feb 18, 2020
He's long owned this. They run diagnostic imaging centres in the U.S. They charge half what hospitals do, which is attracting businesses. AKU has one big competitor in the U.S. that is twice the size of AKU. He believes the competitor will one day buy AKU. He'll wait 18 months for this take-out to happen.
Michael DecterMichael Decter
Owned
Unlock Rating
$4.510

Stock price when the opinion was issued

medical services
TOP PICK

Akumin Inc.(AKU-T)

Jan 22, 2020
Investors don't recognize its value. It can grow inorganically in this environment. A solid business that operates medical MRI clinics, the number two player in the U.S. Payout rates have been very stable. Free cash flow will turn around this year. This should do well this year and boasts a lot of upside. Also, a cheap valuation. (Analysts’ price target is $5.69)
James TelfserJames Telfser
Owned
Unlock Rating
$4.240

Stock price when the opinion was issued

medical services
TOP PICK

Akumin Inc.(AKU-T)

Dec 09, 2019
He picked this last time. It's a great growth-by-acquisition story, buying up medical scanning businesses in Florida and Texas. They're expanding margins to around 25%. They reported a fine quarter lately. Many people are getting MRI scans; hospitals charge a lot for this and insurers are encouraging insurance holders to get these scans in hospitals. AKU is are consolidating what they have now, and they will continue to buy more companies in the years to come. (Analysts’ price target is $7.52)
James TelfserJames Telfser
Owned
Unlock Rating
$4.450

Stock price when the opinion was issued

medical services
TOP PICK

Akumin Inc.(AKU-T)

Nov 14, 2019
Management team has done a good job in MRI and CT scan clinics in the US. Pretty good market with higher margins than closest competitor. Point of inflection to becoming a big consolidator. No dividend. (Analysts’ price target is $5.92)
James TelfserJames Telfser
Owned
Unlock Rating
$4.280

Stock price when the opinion was issued

medical services
TOP PICK

Akumin Inc.(AKU-T)

Nov 12, 2019
They do diagnostic imaging work all in the US, though it's a Canadian company. They're #2 in American diganostic imaging centres. They keep growing. He only wishes the CEO would speak to investors more. (Analysts’ price target is $7.83)
Michael DecterMichael Decter
Owned
Unlock Rating
$2.900

Stock price when the opinion was issued

medical services
TOP PICK

Akumin Inc.(AKU-T)

Oct 15, 2019
It hasn't been getting love. Its business is in the U.S. They've executed very well. They operate MRI and CT scan clinics, as one of the biggest players in the States. They're in a 20% EBITDA business. Aging demographics are a huge tailwind, and Americans prefer going to clinics than pricier hospitals. (Analysts’ price target is $5.92)
James TelfserJames Telfser
Owned
Unlock Rating
$2.730

Stock price when the opinion was issued

medical services
BUY

Akumin Inc.(AKU-T)

Apr 15, 2019
A longtime favourite of his. AKU is a consolidator of imaging centres (x-rays, CAT scans, MRIs) at outpatient centres. There are bigger competitors, but they're trading at a higher 9x multiple than AKU. AKU trades around 8x. Today's acquisition was at 7x and addeds $30 million more EBITDA. There's still lots of consolidation to go in the U.S. So AKU can keep buying. Lots of runway ahead.
Michael DecterMichael Decter
Owned
Unlock Rating
$3.950

Stock price when the opinion was issued

medical services
Showing 1 to 15 of 17 entries
Next PageNext Page

Akumin Inc.(AKU-T) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Akumin Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Akumin Inc.(AKU-T) Frequently Asked Questions

What is Akumin Inc. stock symbol?

Akumin Inc. is a Canadian stock, trading under the symbol AKU-T on the Toronto Stock Exchange (AKU-CT). It is usually referred to as TSX:AKU or AKU-T

Is Akumin Inc. a buy or a sell?

In the last year, there was no coverage of Akumin Inc. published on Stockchase.

Is Akumin Inc. a good investment or a top pick?

Akumin Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Akumin Inc..

Why is Akumin Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Akumin Inc. worth watching?

0 stock analysts on Stockchase covered Akumin Inc. In the last year. It is a trending stock that is worth watching.

What is Akumin Inc. stock price?

On 2024-02-01, Akumin Inc. (AKU-T) stock closed at a price of $0.53.

Build our watch list

Sign in to track investments
you care about

Latest Buy Signals

NEO-T -0.09$11.02
EG-N -0.24$347.8
CJT-T 3.67$95.02
LNR-T 1.04$61.04
FIVE-Q 18.24$103.49

Today's Top Picks

PINS-N 3.62$32.84
OWL-N 1.16$19.64
AC-T 0.83$18.37
LVMUY-… 0$112.11
ACN-N 14.19$322.09

Popular Articles

Latest Sell Signals

ENB-T -2.01$62.29
DVN-N 1.02$33.55
HPE-N 0.85$17.74
CRYPTO… -51.99656590509$2443.61203444739
GOOG-Q 5.2$159.58

Most Recent Experts

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Teal Linde

Teal Linde

Linde Equity Report

Stockchase Insights

Stockchase Insights

5i Research

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Michael Hakes - CFA, MBA

Michael Hakes - CFA, MBA

Murray Wealth Group

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica